Azelastine HCl Ophthalmic Solution
Lack of Assurance of Sterility
Yes — there is an active recall. 2 ongoing FDA recalls mention Azelastine (9 total). Check the affected lots below.
Most common reason: Packaging defect (2 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Azelastine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Lack of Assurance of Sterility
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Defective Container: Potential for broken glass in the neck area of the glass bottles.
Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-oxide
Presence of foreign substance: Potential for glass in the neck area of the glass bottles.
Sun Pharmaceutical is recalling Azelastine HCl Nasal Solution, 0.1% (30 mL Bottle) following a failure to meet the % RSD requirement in the test for Droplet Size during the 6 month long term stability test station
Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
CGMP Deviations: tubing used for filling may interact with the nasal formulation of this product.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.